House Oversight Committee opens probe into FDA’s handling of drug shortages

Re­pub­li­can rep­re­sen­ta­tives lead­ing the House Com­mit­tee on Over­sight and Ac­count­abil­i­ty to­day an­nounced an in­ves­ti­ga­tion in­to FDA’s re­sponse to crit­i­cal US drug short­ages, in­clud­ing com­mon can­cer drugs and an­tibi­otics.

Over­sight Com­mit­tee Chair James Com­er (R-KY) and Health Sub­com­mit­tee Chair Lisa Mc­Clain (R-MI) said they’re con­cerned by the 128 drugs list­ed by the FDA as be­ing in short­age, in­clud­ing com­mon­ly used ones to treat in­fec­tions, can­cer, psy­chi­atric con­di­tions and heart fail­ure.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.